Use "Essential Medicines," Canada as Guides for Drug Pricing

Finding ways to price pharmaceuticals fairly will be a top priority for the next president and Congress. In tackling this thorny issue, they should use the World Health Organization's essential medicines list as a starting point for the discussion and the Canadian system for negotiating drug pricing as a guide. By following those tacks, Mylan's EpiPen could actually play a positive role in restructuring pharmaceutical pricing rather than being the latest scapegoat for how pharmaceutical companies are gouging the American public.